Trikafta 50-25-37.5 MG/75 MG UU 84S
Ended Awarded Last action
- Contract number
- SPE2DR26FCYX7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,854
Award facts
- Contract value 100% obligated
- $18,853.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $18,853.94 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Trikafta 50-25-37.5 mg/75 mg tablets (84-count units). The delivery order, awarded on November 24, 2025, with an ultimate completion date of November 25, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award represents a single delivery order under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
DMS Pharmaceutical Group holds a single-award IDC designated SPE2DR under the PPV-G GEN V program, which was awarded on November 13, 2025, with a $500 million ceiling value and completion date of December 31, 2036. The parent contract positions the contractor as a regional prime vendor supplier within DLA's $30.3 billion pharmaceutical supply chain strategy, authorizing the agency to issue delivery orders for branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare operations globally. The Trikafta delivery order falls within this framework, fulfilling recurring pharmaceutical supply needs for military medical facilities.
Quick answers
Who was awarded contract SPE2DR26FCYX7?
SPE2DR26FCYX7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FCYX7 worth?
The government has obligated $18,854 on SPE2DR26FCYX7.
Is contract SPE2DR26FCYX7 an order under another contract?
Yes. SPE2DR26FCYX7 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCYX7 competed?
The extent of competition for SPE2DR26FCYX7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award